Novo Nordisk A/S - stock earnings
NVO Upcoming estimated earnings
| Date | Low Revenue | Average Revenue | High Revenue |
|---|---|---|---|
| May 2, 2024, midnight | 1.3 billion | 1.4 billion | 1.4 billion |
NVO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 3.3 billion USD | 9.8 billion USD |
| 2023Q3 | 3.2 billion USD | 8.3 billion USD |
| 2023Q2 | 2.8 billion USD | 7.9 billion USD |
| 2023Q1 | 2.9 billion USD | 7.8 billion USD |
| 2022Q4 | 2.0 billion USD | 6.9 billion USD |
| 2022Q3 | 1.9 billion USD | 6.0 billion USD |
| 2022Q2 | 1.9 billion USD | 5.8 billion USD |
| 2022Q1 | 2.1 billion USD | 6.3 billion USD |
| 2021Q4 | 1.7 billion USD | 5.9 billion USD |
| 2021Q3 | 1.9 billion USD | 5.5 billion USD |
| 2021Q2 | 1.9 billion USD | 5.3 billion USD |
| 2021Q1 | 2.0 billion USD | 5.3 billion USD |
| 2020Q4 | 1.5 billion USD | 5.3 billion USD |
| 2020Q3 | 1.6 billion USD | 4.9 billion USD |
| 2020Q2 | 1.6 billion USD | 4.5 billion USD |
| 2020Q1 | 1.8 billion USD | 5.0 billion USD |
| 2019Q4 | 1.3 billion USD | 4.9 billion USD |
| 2019Q3 | 1.5 billion USD | 4.4 billion USD |
| 2019Q2 | 1.5 billion USD | 4.6 billion USD |
| 2019Q1 | 1.6 billion USD | 4.4 billion USD |
| 2018Q4 | 1.3 billion USD | 4.6 billion USD |
| 2018Q3 | 1.4 billion USD | 4.3 billion USD |
| 2018Q2 | 1.6 billion USD | 4.3 billion USD |
| 2018Q1 | 1.8 billion USD | 4.4 billion USD |
| 2017Q4 | 1.3 billion USD | 4.5 billion USD |
| 2017Q3 | 1.5 billion USD | 4.2 billion USD |
| 2017Q2 | 1.5 billion USD | 4.4 billion USD |
| 2017Q1 | 1.5 billion USD | 4.1 billion USD |
| 2016Q4 | 1.2 billion USD | 4.2 billion USD |
| 2016Q3 | 1.5 billion USD | 4.1 billion USD |
| 2016Q2 | 1.5 billion USD | 4.1 billion USD |
| 2016Q1 | 1.4 billion USD | 4.1 billion USD |
| 2015Q4 | 1.2 billion USD | 4.2 billion USD |
| 2015Q3 | 1.3 billion USD | 4.0 billion USD |
| 2015Q2 | 1.3 billion USD | 4.1 billion USD |
| 2015Q1 | 1.4 billion USD | 3.7 billion USD |
| 2014Q4 | 1.1 billion USD | 4.0 billion USD |
| 2014Q3 | 1.1 billion USD | 3.8 billion USD |
| 2014Q2 | 1.3 billion USD | 4.0 billion USD |
| 2014Q1 | 1.2 billion USD | 3.7 billion USD |
| 2013Q4 | 1.1 billion USD | 4.0 billion USD |
| 2013Q3 | 1.2 billion USD | 3.7 billion USD |
| 2013Q2 | 1.2 billion USD | 3.7 billion USD |
| 2013Q1 | 1.0 billion USD | 3.4 billion USD |
| 2012Q4 | 1.0 billion USD | 3.7 billion USD |
| 2012Q3 | 981.6 million USD | 3.4 billion USD |
| 2012Q2 | 895.0 million USD | 3.3 billion USD |
| 2012Q1 | 834.9 million USD | 3.2 billion USD |
| 2011Q4 | 817.3 million USD | 3.2 billion USD |
| 2011Q3 | 767.1 million USD | 3.0 billion USD |
| 2011Q2 | 802.5 million USD | 3.1 billion USD |
| 2011Q1 | 771.3 million USD | 3.0 billion USD |
| 2010Q4 | 704.1 million USD | 2.9 billion USD |
| 2010Q3 | 655.7 million USD | 2.9 billion USD |
| 2010Q2 | 582.5 million USD | 2.5 billion USD |
| 2010Q1 | 603.1 million USD | 2.5 billion USD |
| 2009Q4 | 447.3 million USD | 2.5 billion USD |
| 2009Q3 | 542.4 million USD | 2.5 billion USD |
| 2009Q2 | 563.9 million USD | 2.5 billion USD |
| 2009Q1 | 480.2 million USD | 2.2 billion USD |
| 2008Q4 | 440.9 million USD | 2.4 billion USD |
| 2008Q3 | 503.3 million USD | 2.1 billion USD |
| 2008Q2 | 522.5 million USD | 2.3 billion USD |
| 2008Q1 | 460.0 million USD | 2.2 billion USD |
| 2007Q4 | 194.5 million USD | 2.2 billion USD |
| 2007Q3 | 417.8 million USD | 2.0 billion USD |
| 2007Q2 | 664.4 million USD | 1.9 billion USD |
| 2007Q1 | 306.2 million USD | 1.8 billion USD |
| 2006Q4 | 305.1 million USD | 1.9 billion USD |
| 2006Q3 | 301.7 million USD | 1.6 billion USD |
| 2006Q2 | 299.1 million USD | 1.7 billion USD |
| 2006Q1 | 196.9 million USD | 1.5 billion USD |
| 2005Q4 | 189.1 million USD | 1.5 billion USD |
| 2005Q3 | 282.1 million USD | 1.4 billion USD |
| 2005Q2 | 272.8 million USD | 1.3 billion USD |
| 2005Q1 | 214.0 million USD | 1.3 billion USD |
| 2004Q4 | 263.3 million USD | 1.5 billion USD |
| 2004Q3 | 208.0 million USD | 1.2 billion USD |
| 2004Q2 | 193.8 million USD | 1.1 billion USD |
| 2004Q1 | 176.9 million USD | 1.1 billion USD |
| 2003Q4 | 230.3 million USD | 1.2 billion USD |
| 2003Q3 | 177.9 million USD | 1.1 billion USD |
| 2003Q2 | 196.6 million USD | 997.1 million USD |
| 2003Q1 | 159.6 million USD | 893.5 million USD |
| 2002Q4 | 164.5 million USD | 943.3 million USD |
| 2002Q3 | 132.8 million USD | 855.7 million USD |
| 2002Q2 | 113.4 million USD | 708.7 million USD |
| 2002Q1 | 119.6 million USD | 763.2 million USD |
| 2001Q4 | 120.8 million USD | 770.7 million USD |
| 2001Q3 | 129.3 million USD | 816.8 million USD |
| 2001Q2 | 96.0 million USD | 654.5 million USD |
| 2001Q1 | 120.9 million USD | 632.7 million USD |
| 2000Q4 | 77.6 million USD | 270.1 million USD |
| 2000Q3 | 205.2 million USD | 1.8 billion USD |
| 2000Q2 | 119.4 million USD | 830.6 million USD |
| 2000Q1 | 88.0 million USD | 713.7 million USD |
| 1999Q4 | 89.7 million USD | 750.8 million USD |
| 1999Q3 | 92.8 million USD | 850.3 million USD |
| 1999Q2 | 92.6 million USD | 733.4 million USD |
| 1999Q1 | 71.4 million USD | 676.2 million USD |
| 1998Q4 | 87.5 million USD | 711.8 million USD |
| 1998Q3 | 88.1 million USD | 735.2 million USD |
| 1998Q2 | 107.3 million USD | 667.0 million USD |
| 1998Q1 | 85.4 million USD | 612.2 million USD |
| 1997Q4 | 94.7 million USD | 684.5 million USD |
| 1997Q3 | 87.2 million USD | 630.2 million USD |
| 1997Q2 | 80.5 million USD | 602.3 million USD |
| 1997Q1 | 57.8 million USD | 529.6 million USD |
| 1996Q4 | 67.4 million USD | 613.5 million USD |
| 1996Q3 | 68.4 million USD | 535.7 million USD |
| 1996Q2 | 67.7 million USD | 512.2 million USD |
| 1996Q1 | 58.2 million USD | 501.5 million USD |
| 1995Q4 | 51.0 million USD | 498.0 million USD |
| 1995Q3 | 64.5 million USD | 469.9 million USD |
| 1995Q2 | 65.4 million USD | 521.8 million USD |
| 1995Q1 | 44.8 million USD | 492.2 million USD |
| 1994Q4 | 72.3 million USD | 519.4 million USD |
| 1994Q3 | 55.9 million USD | 492.8 million USD |
| 1994Q2 | 41.0 million USD | 499.8 million USD |
| 1994Q1 | 39.1 million USD | 454.3 million USD |
| 1993Q4 | 61.8 million USD | 619.3 million USD |
| 1993Q3 | 59.5 million USD | 457.2 million USD |
| 1993Q2 | 42.9 million USD | 438.6 million USD |
| 1993Q1 | 42.2 million USD | 383.5 million USD |
| 1992Q4 | 57.7 million USD | 396.3 million USD |
| 1992Q3 | 33.4 million USD | 374.6 million USD |
| 1992Q2 | 49.0 million USD | 410.2 million USD |
| 1992Q1 | 47.3 million USD | 388.7 million USD |
| 1991Q4 | ? USD | 429.9 million USD |
| 1991Q3 | ? USD | 349.4 million USD |
| 1991Q2 | ? USD | 328.4 million USD |
| 1991Q1 | ? USD | 332.4 million USD |
| 1990Q4 | ? USD | 339.6 million USD |
| 1990Q3 | ? USD | 296.3 million USD |
| 1990Q2 | ? USD | 296.6 million USD |
| 1990Q1 | ? USD | 283.3 million USD |
| 1989Q4 | ? USD | 313.2 million USD |
| 1989Q3 | ? USD | 255.2 million USD |
| 1989Q2 | ? USD | 256.6 million USD |
| 1989Q1 | ? USD | 288.5 million USD |
| 1988Q4 | ? USD | 238.9 million USD |
| 1988Q3 | ? USD | 192.8 million USD |
| 1988Q2 | ? USD | 202.5 million USD |
| 1988Q1 | ? USD | 173.4 million USD |
| 1987Q4 | ? USD | 202.0 million USD |
| 1987Q3 | ? USD | 185.6 million USD |
| 1987Q2 | ? USD | 170.5 million USD |
| 1987Q1 | ? USD | 179.3 million USD |
| 1986Q4 | ? USD | 152.5 million USD |
| 1986Q3 | ? USD | 148.1 million USD |
| 1986Q2 | ? USD | 162.1 million USD |
| 1986Q1 | ? USD | 149.7 million USD |
| 1985Q4 | ? USD | 152.1 million USD |
| 1985Q3 | ? USD | 144.0 million USD |
NVO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 12.4 billion USD | 34.4 billion USD |
| 2022 | 8.0 billion USD | 25.5 billion USD |
| 2021 | 7.3 billion USD | 21.5 billion USD |
| 2020 | 6.9 billion USD | 20.8 billion USD |
| 2019 | 5.8 billion USD | 18.3 billion USD |
| 2018 | 5.9 billion USD | 17.1 billion USD |
| 2017 | 6.1 billion USD | 17.9 billion USD |
| 2016 | 5.4 billion USD | 15.9 billion USD |
| 2015 | 5.1 billion USD | 15.8 billion USD |
| 2014 | 4.3 billion USD | 14.5 billion USD |
| 2013 | 4.7 billion USD | 15.5 billion USD |
| 2012 | 3.8 billion USD | 13.8 billion USD |
| 2011 | 3.0 billion USD | 11.6 billion USD |
| 2010 | 2.6 billion USD | 10.8 billion USD |
| 2009 | 2.1 billion USD | 9.8 billion USD |
| 2008 | 1.8 billion USD | 8.5 billion USD |
| 2007 | 1.7 billion USD | 8.2 billion USD |
| 2006 | 1.1 billion USD | 6.9 billion USD |
| 2005 | 929.5 million USD | 5.4 billion USD |
| 2004 | 922.9 million USD | 5.3 billion USD |
| 2003 | 823.8 million USD | 4.5 billion USD |
| 2002 | 577.5 million USD | 3.6 billion USD |
| 2001 | 456.4 million USD | 2.8 billion USD |
| 2000 | 385.1 million USD | 2.6 billion USD |
| 1999 | 325.3 million USD | 2.8 billion USD |
| 1998 | 351.7 million USD | 2.6 billion USD |
| 1997 | 324.0 million USD | 2.5 billion USD |
| 1996 | 263.2 million USD | 2.2 billion USD |
| 1995 | 228.0 million USD | 2.0 billion USD |
| 1994 | 209.0 million USD | 2.0 billion USD |
| 1993 | 208.9 million USD | 1.9 billion USD |
| 1992 | 185.8 million USD | 1.6 billion USD |
| 1991 | 135.8 million USD | 1.4 billion USD |
| 1990 | 111.0 million USD | 1.2 billion USD |
| 1989 | 108.9 million USD | 1.1 billion USD |
| 1988 | 93.1 million USD | 822.0 million USD |
| 1987 | 70.1 million USD | 734.1 million USD |
| 1986 | 76.1 million USD | 611.4 million USD |
| 1985 | 88.7 million USD | 607.2 million USD |
NVO
Price: $128.64
52 week price:
Dividend Yield: 0.07%
5-year range yield:
Forward Dividend Yield: 1.03%
Payout Ratio: 49.35%
Payout Ratio Range:
Dividend Per Share: 1.33 USD
Earnings Per Share: 2.68 USD
P/E Ratio: 44.61
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Volume: 1.1 million
Ebitda: 1.9 billionMarket Capitalization: 564.6 billion
Average Dividend Frequency: 1
Years Paying Dividends: 43
DGR3: 12.61%
DGR5: 6.80%
DGR10: 30.00%
DGR20: 30.00%